Analysts are speculating about the post COVID-19 business environment because so much is changing at a rapid pace. Will globalization remain a key strategy for U.S. businesses? Will companies bring manufacturing back to the U.S. in large numbers? How will supply chains change? Which products will the government require to be manufactured in the United States in the future, like antibiotics?

These are just a few of the questions being debated, but they need long-range answers. As SMEs and diverse businesses confront the COVID-19 crisis, maybe it is time to focus on the opportunities presented in the present.

It is difficult to think of the COVID-19 crisis as a time of o....